New patent expiration for Mallinckrodt Hosp drug OFIRMEV

Annual Drug Patent Expirations for OFIRMEV Ofirmev is a drug marketed by Mallinckrodt Hosp and is included in one NDA. It is available from two suppliers. There are five patents…

The post New patent expiration for Mallinckrodt Hosp drug OFIRMEV appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.